RESEARCH-USE BIOSIMILAR ANTIBODY
Vorsetuzumab
Antibody-drug conjugate · IgG1
Vorsetuzumab (Anti-Human CD70 Recombinant Antibody) is a human anti-CD70 antibody. Vorsetuzumab enhances macrophage-related phagocytosis of renal carcinoma cells, shows inhibitory efficacy against Burkitt’s lymphoma.
TARGETTNFSF7
YAntibody-drug conjugate
CATALOGSC-BS-030
CATALOG NUMBERSC-BS-030
MOLECULAR WEIGHTApprox. 146.1 kDa
PRODUCT FORMATAntibody-drug conjugate
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Vorsetuzumab (Anti-Human CD70 Recombinant Antibody) is a human anti-CD70 antibody. Vorsetuzumab enhances macrophage-related phagocytosis of renal carcinoma cells, shows inhibitory efficacy against Burkitt’s lymphoma.
Vorsetuzumab is a recombinant research-use antibody directed against TNFSF7.